Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ina Oehme

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Histone deacetylase 8 in neuroblastoma tumorigenesisIna Oehme, Hedwig E Deubzer, Dennis Wegener, et al.
Leukemia|September 19, 2024
Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteinsMelisa Halilovic, Mohamed Abdelsalam, Joanna Zabkiewicz, et al.
Cell Death & Disease|August 25, 2017
Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistanceCorinna Bingel, Emily Koeneke, Johannes Ridinger, et al.
Journal of Medicinal Chemistry|April 10, 2019
Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is ImplicatedMagalie Géraldy, Michael Morgen, Peter Sehr, et al.
Scientific Reports|July 4, 2018
Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistanceJohannes Ridinger, Emily Koeneke, Fiona R Kolbinger, et al.
The Biochemical Journal|April 4, 2008
Identification of novel small-molecule histone deacetylase inhibitors by medium-throughput screening using a fluorigenic assayDennis Wegener, Christian Hildmann, Daniel Riester, et al.
International Journal of Molecular Sciences|July 27, 2022
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma ActivitySalma Darwish, Ehab Ghazy, Tino Heimburg, et al.
Angewandte Chemie (International Ed. in English)|October 17, 2025
Identification of a Proteolysis-Targeting-Chimera that Addresses Activated Checkpoint Kinase-1 Reveals its Non-Catalytic Functions in Tumor CellsRamy Ashry, Mohamed Abdelsalam, Julia Hausen, et al.
Cell Cycle (Georgetown, Tex.)|April 11, 2018
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitorsMichael Daskalakis, David Brocks, Yi-Hua Sheng, et al.
Journal of Neuro-Oncology|October 12, 2012
HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatmentTill Milde, Marco Lodrini, Larissa Savelyeva, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Histone deacetylase 8 in neuroblastoma tumorigenesisIna Oehme, Hedwig E Deubzer, Dennis Wegener, et al.
Leukemia|September 19, 2024
Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteinsMelisa Halilovic, Mohamed Abdelsalam, Joanna Zabkiewicz, et al.
Cell Death & Disease|August 25, 2017
Three-dimensional tumor cell growth stimulates autophagic flux and recapitulates chemotherapy resistanceCorinna Bingel, Emily Koeneke, Johannes Ridinger, et al.
Journal of Medicinal Chemistry|April 10, 2019
Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is ImplicatedMagalie Géraldy, Michael Morgen, Peter Sehr, et al.
Scientific Reports|July 4, 2018
Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistanceJohannes Ridinger, Emily Koeneke, Fiona R Kolbinger, et al.
The Biochemical Journal|April 4, 2008
Identification of novel small-molecule histone deacetylase inhibitors by medium-throughput screening using a fluorigenic assayDennis Wegener, Christian Hildmann, Daniel Riester, et al.
International Journal of Molecular Sciences|July 27, 2022
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma ActivitySalma Darwish, Ehab Ghazy, Tino Heimburg, et al.
Angewandte Chemie (International Ed. in English)|October 17, 2025
Identification of a Proteolysis-Targeting-Chimera that Addresses Activated Checkpoint Kinase-1 Reveals its Non-Catalytic Functions in Tumor CellsRamy Ashry, Mohamed Abdelsalam, Julia Hausen, et al.
Cell Cycle (Georgetown, Tex.)|April 11, 2018
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitorsMichael Daskalakis, David Brocks, Yi-Hua Sheng, et al.
Journal of Neuro-Oncology|October 12, 2012
HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatmentTill Milde, Marco Lodrini, Larissa Savelyeva, et al.
Pageof 9